Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Novartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal

Parthika Patel3 Aug 2025 9:30 AM IST

New Delhi: Novartis Healthcare Private Limited has been directed by the Subject Expert Committee (SEC) functional under the Central Drugs Standard...

Biodeal Told To Justify Novel Delivery Claim In NPPA Exemption Plea For Midazolam Nasal Spray

Parthika Patel2 Aug 2025 4:51 PM IST

New Delhi: Biodeal Pharmaceuticals Limited has been directed by the National Pharmaceutical Pricing Authority (NPPA) to submit documents supporting...

CDSCO Panel Accepts Phase I Trial Data for Intas' Denosumab Biosimilar

Parthika Patel2 Aug 2025 4:40 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Analgesic and Rheumatology division of the Central Drugs Standard Control Organisation (CDSCO)...

CDSCO Panel Clears PURE & CURE's Sickle Cell Trial With Conditions On Sample Size, Sites

Parthika Patel1 Aug 2025 5:09 PM IST

New Delhi: PURE & CURE Healthcare Pvt. Ltd. has received a recommendation from the Subject Expert Committee (SEC) under the Central Drugs Standard...

CDSCO Panel Withholds Nod for Syngene's Pegfilgrastim Trial, Seeks Additional Data

Parthika Patel31 July 2025 2:01 PM IST

New Delhi: The Subject Expert Committee under the Central Drugs Standard Control Organisation (CDSCO) has directed Syngene International Limited to...

Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived

Parthika Patel31 July 2025 1:49 PM IST

New Delhi: Zydus Lifesciences Limited has been directed to conduct a Phase III clinical trial in the Indian population for its proposed oncology drug...

AbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker Gilgamesh

Parthika Patel31 July 2025 10:30 AM IST

Bengaluru: Drugmaker AbbVie is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about...

GSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031

Parthika Patel31 July 2025 10:15 AM IST

Bengaluru: British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after second-quarter sales and earnings...

CDSCO Introduces QR Code System for Streamlined Visitor Entry

Parthika Patel30 July 2025 3:53 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has launched a new QR code-based online appointment system to simplify the process...

NPPA Approves Separate Price for GSK's New Paracetamol-Phenylephrine Sachet

Parthika Patel29 July 2025 10:12 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has...

Ranitidine Under Cancer Cloud: CDSCO Calls for Monitoring NDMA Levels, Shelf Life Cuts

Parthika Patel28 July 2025 6:27 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a directive to all...

E-Pharmacy Threat Growing Unchecked: AIOCD Flags Regulatory Failure, Calls for Urgent CDSCO Action

Parthika Patel28 July 2025 6:25 PM IST

New Delhi: The All-India Organisation of Chemists and Druggists (AIOCD) has raised serious concerns over the illegal sale of prescription medicines by...

Journal Club Today

Health News Today

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok